The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
Chimeric antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymphocytes are engineered with synthetic receptors known as chimeric antigen receptors (CAR). The CAR-T cell is an effector T cell that recognizes and eliminates specific cancer cells, independent of maj...
Saved in:
Main Authors: | Zijun Zhao (Author), Yu Chen (Author), Ngiambudulu M. Francisco (Author), Yuanqing Zhang (Author), Minhao Wu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advantages and Applications of CAR-Expressing Natural Killer Cells
by: Wolfgang eGlienke, et al.
Published: (2015) -
Application of cell-derived exosomes in the hematological malignancies therapy
by: Kazem Ghaffari, et al.
Published: (2023) -
Comment on "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 - 2023"
by: Hua Zhao, et al.
Published: (2024) -
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
by: Laura Castelletti, et al.
Published: (2021) -
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023
by: Qing Huang, et al.
Published: (2024)